SERUM BRAIN DERIVED NEUROTROPHIC FACTOR AS BIOMARKER FOR EPILEPSY DIAGNOSIS IN EGYPTIAN CHILDREN WITH EPILEPSY; RELATIONSHIP TO DISEASE SEVERITY AND COGNITIVE FUNCTION.
DOI:
https://doi.org/10.22159/ajpcr.2018.v11i1.21961Keywords:
Epilepsy, Brain-derived neurotrophic factor, Egyptian children, Cognitive function, Disease severityAbstract
 Objectives: This study was designed to estimate serum brain-derived neurotrophic factor (BDNF) concentration in a group of Egyptian children with epilepsy to clarify its utility as a biomarker for epilepsy diagnosis and to evaluate its relationship with their cognitive function and disease severity.
Methods: Intelligence was assessed using Arabic version of the WISC-R test. Serum concentration of BDNF was assessed using enzyme-linked immunosorbent assay in 40 children with epilepsy and 40 apparently healthy children of matched age and sex controls.
Results: Of total 40 epileptic patients aged 6–12 years, the mean age was 8.32 ± 0.7 years and male to female ratio was 1.5:1. The mean serum BDNF concentration and cognitive IQ scores were statistically significantly reduced in the studied patient's group versus to controls (p<0.001). There were highly significant differences in serum BDNF concentration as regards epileptic severity. Serum concentration of BDNF showed significantly positive correlation with cognitive, verbal, performance, and totals IQ scores and negative correlation with the age at the onset of seizures, and duration of therapy. The linear regression analysis showed a statistically significant association between age at the onset of seizures, duration of therapy, cognitive function, and serum BDNF concentrations among the studied patients.
Conclusions: Concentration of BDNF in serum is involved in the mechanism of epileptogenesis in children with epilepsy. It should be used as a helpful marker for epilepsy diagnosis and detection of severity.
Downloads
References
Arulsamy A, Goh BH, Shaikh MF. Current status of epilepsy in Malaysia and way ahead. Int J Pharm Pharm Sci 2015;7:2-5.
Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, et al. Seizures and epilepsy in children: Classification, etiology, and clinical features. Epilepsia 2010;51:676.
Russ SA, Larson K, Halfon N. A national profile of childhood epilepsy and seizure disorder. Pediatrics 2012;129:256-64.
Tapia-Arancibia L, Rage F, Givalois L, Arancibia S. Physiology of BDNF: Focus on hypothalamic function. Front Neuroendocrinol 2004;25:77-107.
Scharfman HE. Brain-derived neurotrophic factor and epilepsy-a missing link? Epilepsy Curr 2005;5:83-8.
Binder DK, Scharfman HE. Brain-derived neurotrophic factor. Growth Factors 2004;22:123-31.
Murray KD, Isackson PJ, Eskin TA. Altered mRNA expession forbrain-derived neurotrophic factor and Type II calcium/calmoduline-dependent protein kinase in the hippocampus of children with intractable temporal lobe epilepsy. J Comp Neurol 2000;418:411-22.
Kanemoto K, Kawasaki J, Tarao Y. Association of partial epilepsy with brain-derived neurotrophic factor [BDNF] gene polymorphism. Epilepsy Res 2003;53:255-8.
Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, et al. ILAE official report: A practical clinical definition of epilepsy. Epilepsia 2014;55:475-82.
International League Against Epilepsy Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1993; 34:592–596.
Sarma P, Bhattacharyya A. Models of epilepsy used in antiepileptic drug discovery. Int J Pharm Pharm Sci 2014;6:1-7.
Wechsler D. Manual for the Wechsler Intelligence Scale for Children-Revised. 4th ed. [WISC-IVs]. 20. San Antonio, Texas: The Psychological Corporation; 2008. p. 377-84.
Huang EJ, Reichardt LF. Neurotrophins: Roles in neuronal development and function. Annu Rev Neurosci 2001;24:677-736.
Hong Z, Li W, Qu B, Zou X, Chen J, Sander JW, et al. Serum brain-derived neurotrophic factor levels in epilepsy. Eur J Neurol 2014;21:57-64.
Connolly AM, Chez M, Streif EM, Keeling RM, Golumbek PT, Kwon JM, et al. Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy. Biol Psychiatry 2006;59:354-63.
Shinnar S, Pellock JM. Update on the epidemiology and prognosis of pediatric epilepsy. J Child Neurol 2002;17 Suppl 1:S4-17.
LaFrance WC Jr, Leaver K, Stopa EG, Papandonatos GD, Blum AS. Decreased serum BDNF levels in patients with epileptic and psychogenic nonepileptic seizures. Neurology 2010;75:1285-91.
Berg AT, Langfitt JT, Testa FM, Levy SR, DiMario F, Westerveld M, et al. Global cognitive function in children with epilepsy: A community-based study. Epilepsia 2008;49:608-14.
El-Alameey IR, Monir ZM, Eltahlawy E. Neuropsychological problems among Epileptic children in Egypt. Med Res J 2013;12:58-68.
Fatenau PS, Jianzhao SH, Dunn DW, Austin JK. Academic performance in children with epilepsy. J Learn Disabil 2008;41:195-207.
Ibekwe RC, Ojinnaka NC, Iloeje SO. Factors influencing the academic performance of school children with epilepsy. J Trop Pediatr 2007;53:338-43.
Waragai M, Wei J, Fujita M, Nakai M, Ho GJ, Masliah E, et al. Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson’s disease. Biochem Biophys Res Commun 2006;345:967-72.
Erickson KI, Prakash RS, Voss MW, Chaddock L, Heo S, McLaren M, et al. Brain-derived neurotrophic factor is associated with age-related decline in hippocampal volume. J Neurosci 2010;30:5368-75.
Ziegenhorn AA, Schulte-Herbrüggen O, Danker-Hopfe H, Malbranc M, Hartung HD, Anders D, et al. Serum neurotrophins-a study on the time course and influencing factors in a large old age sample. Neurobiol Aging 2007;28:1436-45.
Yasutake C, Kuroda K, Yanagawa T, Okamura T, Yoneda H. Serum BDNF, TNF-alpha and IL-1beta levels in dementia patients: Comparison between Alzheimer’s disease and vascular dementia. Eur Arch Psychiatry Clin Neurosci 2006;256:402-6.
Angelucci F, Spalletta G, di Iulio F, Ciaramella A, Salani F, Colantoni L, et al. Alzheimer’s disease (AD) and Mild Cognitive Impairment (MCI) patients are characterized by increased BDNF serum levels. Curr Alzheimer Res 2010;7:15-20.
Forlenza OV, Diniz BS, Teixeira AL, Ojopi EB, Talib LL, Mendonça VA, et al. Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment. World J Biol Psychiatry 2010;11:774-80.
Unalpa A, Bayram E, Ulusoy S, Uran N, Bayram M, Aydogˇan A, et al. Serum concentration of brain-derived neurotrophic factor in epileptic children. J Pediatr Neurol 2009;7:251-5.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
